Novel effects of the cannabinoid inverse agonist AM 251 on parameters related to metabolic syndrome in obese Zucker rats-Reference-Cited by-同舟云学术

Novel effects of the cannabinoid inverse agonist AM 251 on parameters related to metabolic syndrome in obese Zucker rats

Published:2013-11 Issue:11 Volume:62 Page:1641-1650
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Merroun Ikram,Sánchez-González Cristina,Martínez Rosario,López-Chaves Carlos,Porres Jesús M.,Aranda Pilar,Llopis Juan,Galisteo Milagros,Zarzuelo Antonio,Errami Mohammed,López-Jurado María

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference48 articles.

1. The epidemiology of obesity;Ogden;Gastroenterology,2007

2. Endocannabinoid control of food intake and energy balance;Di Marzo;Nat Med,2005

3. Understanding metabolic homeostasis and imbalance: what is the role of the endocannabinoid system?;Kunos;Am J Med,2007

4. Anandamide induces overeating: mediation by central cannabinoid CB1 receptors;Williams;Psychopharmacology,1999

5. Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase;Kola;J Biol Chem,2005

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel insights and mechanisms of diet-induced obesity: Mid-term versus long-term effects on hepatic transcriptome and antioxidant capacity in Sprague-Dawley rats;Life Sciences;2023-07

2. CB1 Ligand AM251 Induces Weight Loss and Fat Reduction in Addition to Increased Systemic Inflammation in Diet-Induced Obesity;International Journal of Molecular Sciences;2022-09-28

3. Turning the clock forward: New pharmacological and non pharmacological targets for the treatment of obesity;Nutrition, Metabolism and Cardiovascular Diseases;2022-06

4. Novel Noninvasive Approaches to the Treatment of Obesity: From Pharmacotherapy to Gene Therapy;Endocrine Reviews;2021-10-21

5. Obesity as a Condition Determined by Food Addiction: Should Brain Endocannabinoid System Alterations Be the Cause and Its Modulation the Solution?;Pharmaceuticals;2021-09-29